FdaApplication
ANDA 213847
Identifiers
- fda_app_no: ANDA213847
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2022-02-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAPSONE | DAPSONE | 7.5% | GEL;TOPICAL |
1 product